KOLIBRI

8 employees

Next-generation cell-culture platform to unlock biologics manufacturing, starting with gene therapies

Basic info

biotechnology research

Biotechnology

Life Science

gene therapy

Biopharma

biomanufacturing

hardtech

cellculture

Genetics

Medical

Manufacturing

acoustics

biotech

2021

KOLIBRI raised undisclosed on March 6, 2023

Investors: SOSV - The Accelerator VC

KOLIBRI raised undisclosed on July 6, 2022

Investors: BioTools Innovator

KOLIBRI raised undisclosed on April 13, 2021

Investors: SOSV - The Accelerator VC